Features

Breathing Disorders Decoded

Day Apnea®
Repeated episodes of shallow or paused daytime breathing that can lead to serious health risks including hypertension (30% higher risk), stroke, and aggravated symptoms of chronic conditions like PTSD and Tinnitus. What begins as a natural stress response often develops into harmful habitual patterns without proper intervention.

Screen Apnea®
Affecting 80% of professionals, this phenomenon involves unconscious breath-holding during screen use – first documented in Microsoft/Apple research. Unlike temporary pauses, chronic Screen Apnea® disrupts oxygen flow, reduces focus, and increases stress hormones. CMAP’s breakthrough technology actively detects these dangerous patterns through precise nasal/oral airflow monitoring and corrects them via instant haptic feedback, clinically proven to reduce episodes by 70%.

Day Apnea® & Screen Apnea® Management

The Problem

  • Day Apnea®: Episodes of shallow/paused daytime breathing linked to hypertension, heart disease, and stroke (PDF: “Vertical Applications”)

  • Screen Apnea®: 40% of people unconsciously hold their breath during screen use, per Microsoft study (PDF: “Screen Apnea®”)

How CMAP Helps

  • Real-time detection via nasal/oral airflow sensors

  • Instant haptic/audio alerts to restore normal breathing

  • Reduces Screen Apnea® episodes by 70% in clinical trials

Hypertension Therapy

Non-Drug Solution

  • Guides users to 6 breaths/minute, activating the parasympathetic nervous system to lower blood pressure (PDF: “Hypertension Therapy”)
  • FDA-cleared potential as Class II medical device

Proven Results

  • 30% faster blood pressure reduction vs. RESPeRATE device
  • Targets $12B hypertension device market

Research & Clinical Use

For Researchers

  • IoT-enabled for global studies with real-time waveform data
  • Detects:
    • Tachypnea (rapid breathing)
    • Bradypnea (slow breathing)
    • Cheyne-Stokes respiration (PDF: “Research Applications”)

For Clinicians

  • Diagnoses sleep apnea (pending FDA approval)
  • Tracks PTSD/anxiety-related breathing patterns

Why Choose CMAP?

Feature CMAP Chest Bands
Accuracy Direct nasal/oral airflow measurement Measures chest movement (less precise)
Comfort 50g, all-day wearable Bulky and restrictive
Data Access Bluetooth®/WiFi real-time export Limited offline data

(7 patents pending for airflow sensor technology)

Hear From Our Users